David A. Kellough
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
29
Citations
212
Est. group size
~1
Recurring co-author estimate
Active years
15
Publishing since 2012
This record combines material on cancer biology, including a study of a drug (Aurora-A inhibitor) tested against brain tumors (glioblastoma), with more recent work applying artificial intelligence tools to pathology, such as AI-assisted review of biopsy slides for breast and prostate cancer and quality-control systems for digital pathology. Based on the available data, it is unclear whether these represent one continuous research direction or contributions to multiple distinct projects, since many entries are supplemental data/figure files rather than standalone studies.
Publication output was minimal or absent for much of the decade, then rose sharply in 2023 (largely supplemental data files tied to a single study) and has continued at a moderate pace through 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 503 AI-Assisted Breast Biopsy Interpretation in a Two-Reader Crossover Study: Accuracy, Efficiency, and Stain-Contingent Signals
Laboratory Investigation · 2026
- 828 Clinical Utility of Tumor-Detect AI algorithm for Detection of Prostate Cancer on Transurethral Resection Specimens
Laboratory Investigation · 2025
- 1364 An Academic Institution’s Perspective of Manual versus Automated Quality Control Systems for Digital Pathology Workflow
Laboratory Investigation · 2025
- Supplemental Figure S2 from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Supplemental Figure Legend from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Supplemental Figure S1 from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Supplemental Figure S3 from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Supplemental Figure Legend from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Supplemental Figure S1 from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Supplemental Figure S3 from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Supplemental Figure S2 from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Data from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Data from Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma
2023
- Laboratory Investigation×6
- Journal of Pathology Informatics×2
- Modern Pathology×1
- Clinical Breast Cancer×1
- OncoTargets and Therapy×1
- Keith Viccaro
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Kevin P. Weller
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Lei Chang
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Gisela Cairo
Biochemistry, Genetics and Molecular Biology · Indiana University
- Claire Walczak
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile